Schuyler Rogg, MD
Interventional Pain Medicine · Midland, MINPI 1356568406
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,588 of the $3,992 with a category attached, or 64.8%. 22 manufacturers reported payments, led by Si-bone, Inc. at 40.4% of the total. 2025 is the largest year on record at $1,664, 3.0 times the $556 reported in 2019.
Across 87 payments — averaging $45.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$2K
- Abbott$681
- Boston Scientific$407
- Vertos Medical, Inc.$365
- Curonix LLC$179
- Assertio Therapeutics, Inc.$144
- plus $606 from 16 others
What the payments were for
- Travel & lodging$1,40435%
- Food & beverage$2,58865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 9 | $1,612 |
| Abbott | 20 | $681 |
| Boston Scientific | 6 | $407 |
| Vertos Medical, Inc. | 6 | $365 |
| Curonix LLC | 3 | $179 |
| Assertio Therapeutics, Inc. | 10 | $144 |
| Teva Pharmaceuticals USA, Inc. | 8 | $99 |
| Nevro Corp. | 3 | $96 |
| Amgen(2 entities) | 4 | $61 |
| AbbVie | 4 | $59 |
| Vertiflex, Inc. | 1 | $58 |
| Hydrocision, Inc. | 1 | $35 |
| Novartis | 2 | $33 |
| Pacira Therapeutics, Inc. | 1 | $32 |
| Biodelivery Sciences International, Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Pfizer | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,992 in reported general payments places this provider in the 65th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $1,374 |
| Pregabalin | 14 | $794 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $506 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $260 |
| Gabapentin | 21 | $152 |
| Tramadol Hcl | 14 | $76 |
| Methocarbamol | 14 | $46 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Midland
- Spencer BertramMidland$914
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
- Evan PeskinFlint$72K
- Richard FerroLansing$31K
- John ChatasAnn Arbor$29K
- Bryant IttiaraAllen Park$28K
- Fadi DellyWyandotte$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.